Accord Healthcare Recalls Atropine Sulfate Injection for Particulate Matter Contamination
Accord Healthcare is recalling Atropine Sulfate Injection due to the presence of particulate matter identified as fiber. Two lots totaling 2,348 vials have been distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a parenteral (injectable) drug with confirmed physical contamination. While no reported illnesses or injuries are documented, the presence of particulate matter in injectable medications represents a risk-of-harm product where injury has not yet been reported, meeting the rubric criterion for a High (3) severity rating.
Plain-English summary
Accord Healthcare, Inc. is recalling Atropine Sulfate Injection, USP 8 mg per 20 mL (manufactured by Intas Pharmaceuticals Limited in India), due to the presence of particulate matter identified as fiber in the product.
The affected product is supplied in 20 mL multiple-dose vials. Two specific lots have been identified: Lot M2210154 with expiration date 06/2025 and Lot M2212575 with expiration date 08/2025. A total of 2,348 vials have been distributed nationwide within the United States.
Atropine Sulfate is a prescription-only injectable medication. The presence of particulate matter in injectable medications poses a potential health risk and is the reason for this recall.
Healthcare providers and customers who have received affected vials should immediately discontinue use and contact Accord Healthcare for instructions regarding product return and replacement.
The recalled product
- Product
- ATROPINE SULFATE (ATROPINE SULFATE)
- Brand
- ATROPINE SULFATE
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug — Injectable / Parenteral
- Hazard
- particulate-matter
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: M2210154 Exp. date 06/2025
- M2212575 Exp. date 08/2025
UPCs (1)
- 0316729512053
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ATROPINE SULFATE
- ModerateFDA Class III Atropine Sulfate Ophthalmic Solution Recall for Specification Failures
FDA (Drugs) · 2025-01-08
- SevereAtropine Sulfate Injection Recalled for Glass Particulate Matter Contamination
FDA (Drugs) · 2024-01-24
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27